Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

Similar articles for PubMed (Select 20406269)

1.

Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades?

Khan A, Bhat A, Kolts R, Thase ME, Brown W.

CNS Neurosci Ther. 2010 Aug;16(4):217-26. doi: 10.1111/j.1755-5949.2010.00151.x. Epub 2010 Apr 16.

PMID:
20406269
3.
4.

Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.

Khan A, Schwartz K, Kolts RL, Ridgway D, Lineberry C.

Biol Psychiatry. 2007 Jul 1;62(1):65-71. Epub 2006 Dec 4.

PMID:
17141744
5.

Placebo response and antidepressant clinical trial outcome.

Khan A, Detke M, Khan SR, Mallinckrodt C.

J Nerv Ment Dis. 2003 Apr;191(4):211-8.

PMID:
12695731
6.

Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.

Khan A, Brodhead AE, Kolts RL, Brown WA.

J Psychiatr Res. 2005 Mar;39(2):145-50.

PMID:
15589562
7.

Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database.

Khan A, Leventhal RM, Khan SR, Brown WA.

J Clin Psychopharmacol. 2002 Feb;22(1):40-5.

PMID:
11799341
9.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
10.

Factors that influence the outcome of placebo-controlled antidepressant clinical trials.

Niklson IA, Reimitz PE, Sennef C.

Psychopharmacol Bull. 1997;33(1):41-51.

PMID:
9133750
11.
12.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
13.

[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

Gourion D.

Encephale. 2008 Jan;34(1):73-81. doi: 10.1016/j.encep.2007.12.001. Epub 2008 Feb 5. Review. French.

PMID:
18514154
14.

A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.

Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA.

J Clin Psychiatry. 1998 May;59(5):246-53.

PMID:
9632036
15.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
16.

Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.

Reddy S, Kane C, Pitrosky B, Musgnung J, Ninan PT, Guico-Pabia CJ.

Curr Med Res Opin. 2010 Jan;26(1):139-50. doi: 10.1185/03007990903408678. Review.

PMID:
19919295
17.

Antidepressant-placebo differences in 16 clinical trials over 10 years at a single site: role of baseline severity.

Khan A, Bhat A, Faucett J, Kolts R, Brown WA.

Psychopharmacology (Berl). 2011 Apr;214(4):961-5. doi: 10.1007/s00213-010-2107-1. Epub 2010 Dec 2.

PMID:
21125396
18.

Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.

Lucas M, Asselin G, Mérette C, Poulin MJ, Dodin S.

Am J Clin Nutr. 2009 Feb;89(2):641-51. doi: 10.3945/ajcn.2008.26749. Epub 2008 Dec 30.

19.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
20.

Response of anxiety and agitation symptoms during nefazodone treatment of major depression.

Fawcett J, Marcus RN, Anton SF, O'Brien K, Schwiderski U.

J Clin Psychiatry. 1995;56 Suppl 6:37-42.

PMID:
7649972
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk